SCYX Q3 2021 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$37M

Q3 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$516,000

Gross Profit

$371,00071.9% margin

Operating Income

-$19M-3767.6% margin

Net Income

-$605,000-117.2% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$588,000

Balance Sheet

Total Assets

$110M

Total Liabilities

$72M

Stockholders' Equity

$38M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$516,000	$0	—
Gross Profit	$371,000	$0	—
Operating Income	-$19M	-$12M	-68.9%
Net Income	-$605,000	$909,000	-166.6%

Revenue Segments

Product

$516,000100%